APA (7th ed.) Citation

Vollenberg, R., Tepasse, P., Lorentzen, E., & Nowacki, T. M. (2022). Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study. Journal of personalized medicine, 12(5), 694. https://doi.org/10.3390/jpm12050694

Chicago Style (17th ed.) Citation

Vollenberg, Richard, Phil-Robin Tepasse, Eva Lorentzen, and Tobias Max Nowacki. "Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month After Vaccination with the SARS-CoV-2 MRNA Vaccine BNT162b2: A Pilot Study." Journal of Personalized Medicine 12, no. 5 (2022): 694. https://doi.org/10.3390/jpm12050694.

MLA (9th ed.) Citation

Vollenberg, Richard, et al. "Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month After Vaccination with the SARS-CoV-2 MRNA Vaccine BNT162b2: A Pilot Study." Journal of Personalized Medicine, vol. 12, no. 5, 2022, p. 694, https://doi.org/10.3390/jpm12050694.